Plunkett Research Online: Novartis Gene Therapies

NOVARTIS GENE THERAPIES (Subsidiary) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Novartis Gene Therapies, formerly AveXis, Inc., is a clinical-stage gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from rare and life-threatening neurological genetic diseases. The firm’s initial product, Zolgensma (onasemnogene abeparvovec-x.....


NOVARTIS GENE THERAPIES

Ticker: Subsidiary
Exchange:
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 847-857-8280
Fax:
Address: 2275 Half Day Rd., Ste. 160
Bannockburn, IL 60015 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:
Parent Company: Novartis AG

Contacts Description

Vasant (Vas) NarasimhanCEO
Novartis Gene Therapies, formerly AveXis, Inc., is a clinical-stage gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from rare and life-threatening neurological genetic diseases. The firm’s initial product, Zolgensma (onasemnogene abeparvovec-x.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture

Novartis offers its employees a broad range of benefits, including retirement plans, paid leave, incentive programs, career development opportunities, talent matching, hybrid workplaces, comprehensive health insurance, wellness support and more.